Depemokimab was shown to reduce exacerbations in patients with severe asthma. The proportions of adverse events of ...

(Bloomberg) -- GSK Plc and Flagship Pioneering Inc. entered ... Inc. in 2023 for about $2 billion to secure a promising cough ...

GSK has taken another step towards rebuilding ... in late-stage development as a chronic cough therapy. The big pharma needs to boost its pipeline as it is facing patent expiry in 2027 for HIV ...

GSK plc will ... of respiratory medicine and deliver the next generation standard of care for millions of people affected by respiratory conditions like asthma, chronic obstructive pulmonary disease ...

GSK Pharma board approves sale of Vemgal plant to Hetero Labs The board of directors at its meeting held on Tuesday, approved the sale of the company's business undertaking i.e., manufacturing ...

GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. The company's product portfolio includes prescription medicines and ...

GSK lifted its sales and earnings projections for the year, after a strong performance by its HIV and cancer drugs drove second-quarter sales higher. The British pharmaceutical firm said sales ...

Therapeutic area expertise motivated GSK to acquire Bellus Health and develop a new medicine for patients with refractory chronic cough ... agreements with Hansoh Pharma for novel ADCs in oncology.

New Delhi: Following the deaths of at least 141 children worldwide connected to cough ... Pharma firms manufacturing GlaxoSmithKline's T-Minic Oral Drops, Glenmark's Ascoril Flu Syrup, and IPCA ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

The World Health Organization and partners on Friday set up a scheme to help bring mpox vaccines, tests and treatments to the ...